You may have come across MBC clinical practice guidelines. Experts develop clinical practice guidelines by reviewing all available evidence from research and clinical trials and considering balance between benefits and harms, equity, feasibility, and acceptability. Doctors and patients then use these guidelines to select treatments.
Guidelines explain how strong the recommendation is, help establish the standard of care, and are updated as new information from clinical trials emerges.
Click the links below to view information about how National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), National Cancer Institute (NCI), and other experts develop and refine MBC guidelines.
Guidelines for MBC
- National Comprehensive Cancer Network (NCCN): NCCN Guidelines for Patients: Metastatic Breast Cancer
- American Society of Clinical Oncology (ASCO): List of Guidelines Recently Published and In Development
- National Cancer Institute (NCI): MBC Treatment–Patient Version
How Guidelines are Developed
- NCCN: About Clinical Practice Guidelines
- ASCO: What Are Clinical Practice Guidelines and How Do They Impact Care for People With Cancer?
- Mayo Clinic: Development of Clinical Practice Guidelines
- American Academy of Family Physicians: How Clinical Practice Guideline are Established
MBC Clinical Trials
- Metastatic Trial Search: Trials for Collecting Data for Future Treatment Guidelines
Last Modified on March 31, 2023
Tags:ASCOTreatment GuidelinesClinical Trial TermsNavigating Cancer CareFrom the Experts